home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 08/01/25

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - OncoX Deepens ABVC Alliance

CEO Yen Wen Pin’s IPO Vision Gains Traction as OncoX Expands Pipeline SILICON VALLEY, CA - August 1, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (cent...
ABVC - ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma

Total licensing revenue crosses $1.046 million; strategic collaboration with OncoX evolves toward expanded product development and global oncology footprint SILICON VALLEY, CA - July 24, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical comp...

ABVC - ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program

With Total Milestone Payments Reaching $946,000, ABVC Deepens Its Ophthalmology Focus Through a High-potential Partnership With ForSeeCon SILICON VALLEY, CA - July 18, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing the...

ABVC - ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships

Licensing-first Strategy Continues to Deliver Non-dilutive Revenue; ABVC Positions Itself as a Leader in CNS-focused Botanical Therapeutics SILICON VALLEY, CA - July 10, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company d...
ABVC - PRISM Mid-Day Movers: Biotech Breakthroughs and Ethereum Exposure Fuel Gains

2025-07-08 14:00:35 ET ZyVersa Therapeutics Surges 126% on FDA Compassionate Use for Ultra-Rare Kidney Disease ZyVersa Therapeutics, Inc. ( ZVSA ) soared 125.67% to lead the PRISM Emerging Biotech Index after the FDA approved emergency compassionate use of its investigational ...

ABVC - PRISM Mid-Day Movers: Rare Disease Breakthrough and Ethereum Treasury Surge Drive Index Gains

2025-07-07 14:30:42 ET Mustang Bio Rockets 218% After FDA Grants Orphan Drug Designation for CAR-T Therapy Mustang Bio Inc. ( MBIO ) soared 217.73%, dominating the PRISM Emerging Biotech Index , following the FDA's Orphan Drug Designation for MB-101 , its IL13Ra2-targeted ...

ABVC - ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology

SILICON VALLEY, CA - June 26, 2025 ( NEWMEDIAWIRE ) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, proudly announces that a podcast with Biot...
ABVC - ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment

SILICON VALLEY, CA - June 24, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that it has converted...

ABVC - ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million

ABVC's Oncology Licensing to OncoX Highlights Scalable Royalty Strategy SILICON VALLEY, CA - June 6, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervou...

ABVC - ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value

Silicon Valley, CA - ( NewMediaWire ) - June 03, 2025 - – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that its Board ...
Previous 10 Next 10